Feng, X.; Filippini Velázquez, G.; Bohlscheid, S.; Unterfrauner, M.; Anand, P.; Rejeski, H.A.; Hartz, A.; Baudrexler, T.; Schmid, C.; Schmetzer, H.M.
Dendritic Cells of Leukemic Origin (DCleu) Modulate the Expression of Inhibitory Checkpoint Molecules and Their Ligands on T Cells and Blasts in AML Relapse After Allogeneic Stem Cell Transplantation. Cancers 2025, 17, 2948.
https://doi.org/10.3390/cancers17182948
AMA Style
Feng X, Filippini Velázquez G, Bohlscheid S, Unterfrauner M, Anand P, Rejeski HA, Hartz A, Baudrexler T, Schmid C, Schmetzer HM.
Dendritic Cells of Leukemic Origin (DCleu) Modulate the Expression of Inhibitory Checkpoint Molecules and Their Ligands on T Cells and Blasts in AML Relapse After Allogeneic Stem Cell Transplantation. Cancers. 2025; 17(18):2948.
https://doi.org/10.3390/cancers17182948
Chicago/Turabian Style
Feng, Xiaojia, Giuliano Filippini Velázquez, Sophia Bohlscheid, Marianne Unterfrauner, Philipp Anand, Hazal Aslan Rejeski, Anne Hartz, Tobias Baudrexler, Christoph Schmid, and Helga Maria Schmetzer.
2025. "Dendritic Cells of Leukemic Origin (DCleu) Modulate the Expression of Inhibitory Checkpoint Molecules and Their Ligands on T Cells and Blasts in AML Relapse After Allogeneic Stem Cell Transplantation" Cancers 17, no. 18: 2948.
https://doi.org/10.3390/cancers17182948
APA Style
Feng, X., Filippini Velázquez, G., Bohlscheid, S., Unterfrauner, M., Anand, P., Rejeski, H. A., Hartz, A., Baudrexler, T., Schmid, C., & Schmetzer, H. M.
(2025). Dendritic Cells of Leukemic Origin (DCleu) Modulate the Expression of Inhibitory Checkpoint Molecules and Their Ligands on T Cells and Blasts in AML Relapse After Allogeneic Stem Cell Transplantation. Cancers, 17(18), 2948.
https://doi.org/10.3390/cancers17182948